Search Results - "Eviatar, Tali"
-
1
Concurrent myopathy and inflammatory cardiac disease in COVID-19 patients: a case series and literature review
Published in Rheumatology international (01-05-2022)“…Adult COVID-19 patients can present with acute muscle and/or cardiac involvement. Our study aims to describe the incidence and characteristics of patients with…”
Get full text
Journal Article -
2
Diabetic Retinopathy -Incidence And Risk Factors In A Community Setting- A Longitudinal Study
Published in Scandinavian journal of primary health care (01-09-2018)“…Aim: To evaluate the natural history of diabetic retinopathy (DR) in diabetic patients and to assess long term risk for other chronic diseases associated with…”
Get full text
Journal Article -
3
Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage
Published in Lupus science & medicine (24-09-2024)“…ObjectiveTo assess treatment patterns and the association between long-term glucocorticoid (GC) and hydroxychloroquine (HCQ) use and damage accrual in patients…”
Get full text
Journal Article -
4
P55 Treatment patterns, corticosteroid use and associated comorbidities in systemic lupus erythematosus
Published in Lupus science & medicine (14-03-2024)“…ObjectiveTo identify and characterize systemic lupus erythematosus (SLE) patients in Israel, treatment patterns, and the association between cumulative daily…”
Get full text
Journal Article -
5
Heart Valve Surgery in Antiphospholipid Syndrome Patients-Morbidity and Mortality
Published in Life (Basel, Switzerland) (27-03-2023)“…To assess valve surgery outcomes in antiphospholipid syndrome (APS). A retrospective study assessing complications and mortality rate and possible factors…”
Get full text
Journal Article -
6
Case report: Cerebral sinus vein thrombosis in VEXAS syndrome
Published in Frontiers in medicine (08-04-2024)“…VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic) syndrome is a newly described hemato-inflammatory acquired monogenic entity that presents…”
Get full text
Journal Article -
7
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations
Published in Frontiers in immunology (13-03-2023)“…We aimed to characterize the course of COVID-19 in autoimmune inflammatory rheumatic disease (AIIRD) patients in Israel, taking into consideration several…”
Get full text
Journal Article -
8
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study
Published in Vaccines (Basel) (01-02-2023)“…Development of autoantibodies following BNT162b2 mRNA COVID-19 vaccination and their association with disease flares in adult patients with autoimmune…”
Get full text
Journal Article -
9
Systemic Lupus Erythematous and Obstructive Sleep Apnea: A Possible Association
Published in Life (Basel, Switzerland) (01-03-2023)“…Marked fatigue is common in patients with systemic lupus erythematosus (SLE). This study aimed to assess the association of sleep disorders, including…”
Get full text
Journal Article -
10
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
Published in Vaccines (Basel) (06-06-2022)“…Treatment with rituximab (RTX) blunts SARS-CoV-2 vaccination-induced humoral response. We sought to identify predictors of a positive immunogenic response to…”
Get full text
Journal Article -
11
A novel inhibitory pathway of synovial inflammation exerted by glucocorticoids and tumor necrosis factor inhibitors via lymphocyte activation gene-3 up-regulation: an ex-vivo study
Published in Rheumatology (Oxford, England) (25-07-2024)“…To investigate the impact of glucocorticoids (GCs) and anti-rheumatic drugs on the lymphocyte activation gene-3 (LAG-3) and on programmed cell death-1 (PD-1)…”
Get full text
Journal Article -
12
Paraneoplastic Dactylitis Leading to the Diagnosis of Ovarian Cancer
Published in The Israel Medical Association journal (01-05-2019)Get full text
Journal Article -
13
Quality evaluation of the underlying evidence in the updated treatment recommendations for systemic lupus erythematosus
Published in Rheumatology (Oxford, England) (24-12-2021)“…Abstract Objectives SLE is a multisystem autoimmune disorder known for its broad clinical spectrum. Recently, the European, British and Latin American…”
Get full text
Journal Article -
14
Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls
Published in Clinical and experimental immunology (12-07-2024)“…This paper aims to compare the cellular immune response to the SARS-CoV-2 BNT162b2 vaccine of pediatric patients with autoimmune inflammatory rheumatic disease…”
Get full text
Journal Article -
15
Ocular and orbital manifestations in VEXAS syndrome
Published in Eye (London) (01-06-2024)“…Background VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a hematoinflammatory disease that typically affects adults. It results from a…”
Get full text
Journal Article -
16
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel
Published in JAMA : the journal of the American Medical Association (25-01-2022)“…IMPORTANCE: Administration of a BNT162b2 booster dose (Pfizer-BioNTech) to fully vaccinated individuals aged 60 years and older was significantly associated…”
Get full text
Journal Article -
17
Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4–11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter study
Published in Vaccine (02-12-2024)“…This prospective, longitudinal, multicenter study assessed the safety and efficacy of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine among children…”
Get full text
Journal Article -
18
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls
Published in Journal of rheumatology (01-04-2024)“…To assess the humoral response to the BNT162b2 mRNA vaccine among patients with spondyloarthritis (SpA) receiving secukinumab (SEC) compared to those receiving…”
Get full text
Journal Article -
19
Secukinumab real world drug retention compared to TNF-alpha inhibitors in psoriatic arthritis
Published in Clinical and experimental rheumatology (01-01-2022)“…To prospectively study real-world efficacy and safety of secukinumab in psoriatic arthritis (PsA) patients from the Israeli registry of inflammatory diseases…”
Get more information
Journal Article -
20
Prevalence of COVID‐19 and seroprevalence to SARS‐CoV‐2 in a rheumatologic patient population from a tertiary referral clinic in Israel
Published in Internal medicine journal (01-05-2021)“…Background It is unclear if the prevalence of COVID‐19 in rheumatologic patients is similar to that of the general population. There are no reports of…”
Get full text
Journal Article